Annual Report 2021

HOP FUNG GROUP HOLDINGS LIMITED • Annual Report 2021 136 NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED) 綜合財務報表附註（續） FOR THE YEAR ENDED 31ST DECEMBER, 2021 截至二零二一年十二月三十一日止年度 25. 以股份支付之支出 股權支付交易購股權計劃 本公司已於二零一三年六月三日批准及 採納購股權計劃（「該計劃」），主要目的 為對本集團作出貢獻之指定參與者作出 鼓勵或獎賞。 根據該計劃，本公司董事會可向本公 司、其附屬公司或本集團任何成員公司 持有任何股權之任何機構（「所投資機 構」）之合資格僱員（包括執行董事或非 執行董事或獨立非執行董事）授出購股 權，以認購本公司股份。另外，本公司 有權不時授出購股權予任何向本集團之 任何成員公司或任何所投資機構提供貨 物或服務之任何供應商、本集團或任何 所投資機構之任何客戶，以及向本集團 或任何所投資機構提供研究、開發或其 他技術支援服務之任何諮詢人、顧問、 經理、高級職員或機構。 根據該計劃授出之購股權獲全數行使時 可予發行之股份總數，合共不得超逾採 納該計劃之普通決議案獲通過當日本公 司已發行股份之 10% 。於任何時間因行 使根據該計劃授出而未行使之全部購股 權而可予以發行股份之數目，不得超過 本公司不時已發行股本之 30% 。 本公司已於二零一三年六月三日批准及 未經本公司股東根據該計劃事先批准， 向任何個人可能授出之購股權涉及之股 份數目，於任何十二個月期間，均不得 超過本公司於任何時間已發行股份之 1% 。倘向一名主要股東或獨立非執行 董事或任何彼等各自之聯繫人士授出任 何購股權，會導致因授予該人士之所有 購股權獲行使而於截至授出日期（包括 當日）止十二個月期間，已經及將予以 發行之本公司股份，合共佔本公司已發 行股份超過 0.1% ，且價值（根據本公司 股份於每次授出購股權日期之收市價計 算）超過 5,000,000 港元，則根據該計劃 該項授出購股權須事先得到本公司股東 批准。 25. SHARE-BASED PAYMENTS Equity-settled share option scheme The Company approved and adopted a share option scheme (the “Scheme”) on 3rd June, 2013 for the primary purpose of providing incentive or rewards to selected participants for their contribution to the Group. Under the Scheme, the board of directors of the Company may grant options to eligible employees, including executive or non-executive directors (including independent non-executive directors), of the Company, its subsidiaries, or any entity (“Invested Entity”) in which any member of the Group holds any equity interest, to subscribe for shares in the Company. Additionally, the Company may, from time to time, grant share options to any supplier of goods or services to any member of the Group or any Invested Entity, any customer of the Group or any Invested Entity, and any consultants, advisers, managers, officers or entities that provides research, development or other technological support to the Group or any Invested Entity. The total number of shares which may be issued upon exercise of all options to be granted under the Scheme must not in aggregate exceed 10% of the shares of the Company in issue as at the date of the passing of the ordinary resolution for adoption of the Scheme. The number of shares which may be issued upon exercise of all outstanding options granted and yet to be exercised at any time under the Scheme shall not exceed 30% of the issued share capital of the Company from time to time. The number of shares in respect of which options may be granted to any individual in any 12-month period is not permitted to exceed 1% of the shares of the Company in issue at any point in time, without prior approval from the Company’s shareholders in accordance with the Scheme. Where any grant of options to a substantial shareholder or an independent non-executive director or any of their respective associates would result in the shares in the Company issued and to be issued upon exercise of all options to such person in the 12-month period up to and including the date of grant in excess of 0.1% of the shares of the Company in issue and with a value (based on the closing price of the shares of the Company at the offer date of each offer) in excess of HK$5,000,000, such grant of options must be approved in advance by the Company’s shareholders in accordance with the Scheme.